Krishnan Venkatesan, MD
Urology · Washington, DCNPI 1245431998
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,678 of the $3,632 with a category attached, or 73.7%. Boston Scientific accounts for 76.8% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $1,777 and has fallen 85.2% since, to $262 in 2025.
Across 56 payments — averaging $64.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- AbbVie$154
- Coloplast$142
- Endo Pharmaceuticals Inc.$116
- Sumitomo Pharma America, Inc.$73
- Antares Pharma, Inc.$51
- plus $306 from 12 others
What the payments were for
- Travel & lodging$87424%
- Food & beverage$2,67874%
- Education$802%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 26 | $2,791 |
| AbbVie(2 entities) | 7 | $154 |
| Coloplast | 3 | $142 |
| Endo Pharmaceuticals Inc. | 3 | $116 |
| Sumitomo Pharma America, Inc. | 2 | $73 |
| Antares Pharma, Inc. | 2 | $51 |
| Merck | 2 | $47 |
| Progenics Pharmaceuticals, Inc. | 1 | $36 |
| Novartis | 1 | $32 |
| Tolmar, Inc. | 1 | $30 |
| Olympus America Inc. | 1 | $27 |
| Immunitybio, Inc. | 1 | $25 |
| Teleflex LLC | 1 | $20 |
| Rigicon,inc. | 1 | $19 |
| Johnson & Johnson | 1 | $19 |
| Myovant Sciences Inc. | 1 | $18 |
| Davol Inc. | 1 | $18 |
| Cook Medical LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,632 in reported general payments places this provider in the 65th percentile of 47 urology providers in District of Columbia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 78 | $68,218 |
| Trospium Chloride ErTrospium Chloride | 24 | $6,544 |
| Trospium Chloride | 19 | $1,882 |
| Solifenacin Succinate | 22 | $938 |
| Tamsulosin Hcl | 68 | $893 |
| Oxybutynin Chloride ErOxybutynin Chloride | 15 | $403 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 39 | $307 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 14 | $244 |
| Gentamicin Sulfate In NsGentamicin In Nacl, Iso-Osm | 12 | $206 |
| Oxybutynin Chloride | 12 | $193 |
| Cefdinir | 12 | $191 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $85 |
| Oxycodone Hcl | 11 | $35 |
Paid to pharmacies, not to this prescriber.
Other urology in Washington
- Armine SmithWashington$58K
- Nathan ShawWashington$54K
- Lambros StamatakisWashington$39K
- Patrick MufarrijWashington$31K
- Ryan HankinsWashington$29K
- Adam MetwalliWashington$27K
- Michael WhalenWashington$17K
- Pamela ColemanWashington$14K
- Leslie DeaneWashington$13K
- Jason EngelWashington$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.